{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:14:17Z","timestamp":1788232457963,"version":"build-2803163510"},"reference-count":9,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jid.2025.04.011","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T11:38:52Z","timestamp":1746272332000},"page":"2354-2355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Challenges with Using the FDA Adverse Event Reporting System to Evaluate the Risk of Benzoyl Peroxide\u2013Containing Products"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5467-4102","authenticated-orcid":false,"given":"John S.","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.04.011_bib1","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.jid.2025.01.027","article-title":"The need for transparency and careful messaging regarding the potential for benzoyl peroxide products to form benzene","volume":"145","author":"Barbieri","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.011_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamadermatol.2024.6443","article-title":"The role of formulation in benzene formation in benzoyl peroxide products","volume":"161","author":"Barbieri","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.04.011_bib3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaad.2024.05.093","article-title":"Benzene in benzoyl peroxide-how worried should we be?","volume":"91","author":"Barbieri","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.011_bib4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1158\/1055-9965.EPI-24-0325","article-title":"Occupational benzene exposure and cancer risk among Chinese men: a report from the shanghai Men\u2019s health study","volume":"33","author":"DeMoulin","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jid.2025.04.011_bib5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jaad.2024.07.011","article-title":"Benzoyl peroxide for acne treatment is not associated with an increased risk of malignancy: a retrospective cohort study","volume":"91","author":"Garate","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.011_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jid.2024.09.009","article-title":"Evaluation of benzene presence and formation in benzoyl peroxide drug products","volume":"145","author":"Kucera","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.011_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.202308-1440OC","article-title":"Long-term exposure to low concentrations of ambient benzene and mortality in a national English cohort","volume":"209","author":"Wang","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jid.2025.04.011_bib9","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.jid.2025.02.139","article-title":"A disproportionality analysis on benzoyl peroxide and its risk of malignancy using the FDA adverse event reporting system","volume":"145","author":"Yang","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.011_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.16787","article-title":"A comprehensive study on adverse reactions of benzoyl peroxide (BPO) in dermatological aesthetics utilizing the FAERS database","volume":"24","author":"Zhou","year":"2025","journal-title":"J Cosmet Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:57:29Z","timestamp":1788231449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25004543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0022202X25004543"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.011","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges with Using the FDA Adverse Event Reporting System to Evaluate the Risk of Benzoyl Peroxide\u2013Containing Products","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Investigative Dermatology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}